(CURE) Direxion Daily Healthcare - NYSE

ETF Category: Trading--Leveraged Equity | Exchange: NYSE (USA) | Market Cap: 167m USD | Total Return: 30.1% in 12m

Leveraged ETFs, Financial Derivatives, Healthcare Equities
Total Rating 49
Safety 34
Buy Signal -0.43
Trading--Leveraged Equity
Category Rotation: -31.0
TER: 0.96%
AUM: 167M
Avg Turnover: 7.48M
Risk 3d forecast
Volatility43.4%
VaR 5th Pctl7.68%
VaR vs Median-1.65%
Reward TTM
Sharpe Ratio0.72
Rel. Str. IBD48.9
Rel. Str. Peer Group42.1
Character TTM
Beta0.888
Beta Downside0.949
Hurst Exponent0.474
Drawdowns 3y
Max DD51.93%
CAGR/Max DD0.05
CAGR/Mean DD0.14

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: CURE Direxion Daily Healthcare

The Direxion Daily Healthcare Bull 3X Shares (CURE) is a leveraged exchange-traded fund designed to provide 300% of the daily performance of the Health Care Select Sector Index. The fund allocates at least 80% of its net assets into financial instruments, such as swap agreements and futures contracts, to achieve this magnification. Its underlying index tracks U.S. companies across sub-sectors including pharmaceuticals, biotechnology, and healthcare equipment.

Leveraged ETFs like CURE are intended for short-term trading rather than long-term investment due to the effects of daily compounding and volatility decay. The healthcare sector is characterized by high research and development costs and significant regulatory oversight from agencies like the FDA, which can lead to sharp price movements in the underlying stocks. Investors should evaluate the specific risks of triple leverage on ValueRay to better understand how these instruments behave over different time horizons.

As a non-diversified fund, CURE has a concentrated exposure to the domestic healthcare industry. Launched in 2011, the fund currently operates with a micro-cap market capitalization of approximately $156 million. Because it resets daily, the funds performance over periods longer than one day can deviate significantly from three times the cumulative return of the benchmark index.

Headlines to Watch Out For
  • Medicare drug price negotiations impact pharmaceutical and biotech margins
  • Federal Reserve interest rate policy dictates healthcare sector equity valuations
  • GLP-1 weight-loss drug demand drives pharmaceutical segment revenue growth
  • Triple leverage amplifies volatility from healthcare regulatory and legislative shifts
What is the price of CURE shares?

As of June 12, 2026, the stock is trading at USD 102.93 with a total of 63,867 shares traded.
Over the past week, the price has changed by +3.90%, over one month by +23.11%, over three months by -0.91% and over the past year by +30.10%.

Is CURE a buy, sell or hold?

Direxion Daily Healthcare has no consensus analysts rating.